Clinical trial
Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions Magnetic Anastomosis System (MAGNET System) to Achieve Duodeno-Ileostomy Diversion in Adults With Obesity and With or Without Type 2 Diabetes Mellitus
NCT05322122 is registered in ClinicalTrials.gov with GT Metabolic Solutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions Magnetic Anastomosis System (MAGNET System) to Achieve Duodeno-Ileostomy Diversion in Adults With Obesity and With or Without Type 2 Diabetes Mellitus
- Lead sponsor
- GT Metabolic Solutions, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 18, 2021
- Completion date
- April 4, 2024
- Enrollment
- 49 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.